Pharma Deals Review, Vol 2008, No 98 (2008)

Font Size:  Small  Medium  Large

Mitsubishi Tanabe Builds its Presence in North America

Taskin Ahmed

Abstract


In its quest to expand its overseas operations in the field of chronic kidney disease, Mitsubishi Tanabe licensed Cytochroma’s vitamin D analogue, CTA018 , and acquired a stake in the Canadian company.

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.